trending Market Intelligence /marketintelligence/en/news-insights/trending/QZdTzhGCJ17-m__M5ooEGg2 content esgSubNav
In This List

Novadaq receives court approval for Stryker deal

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Novadaq receives court approval for Stryker deal

Novadaq Technologies Inc. said the Ontario Superior Court of Justice has approved its acquisition by Stryker Corp. for $11.75 per share in cash.

The acquisition, which has been approved by Novadaq shareholders, is still subject to regulatory approvals under the Canadian Competition Act and U.S. Hart-Scott-Rodino and the satisfaction of certain other customary closing conditions.

The transaction is expected to close in the third quarter of 2017.